Solazyme patents use of algal biomass for diabetes treatment

06/16/2014 | Seeking Alpha

Solazyme and the University of Manitoba have received a patent for the use of algal biomass in treating impaired glucose metabolism. The patent describes the use of Chlorella protothecoides as an alternative treatment to reduce blood glucose, body fat and cholesterol and to increase beneficial gut bacteria.

View Full Article in:

Seeking Alpha

Published in Brief: